Disequilibrium: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) No edit summary |
No edit summary |
||
| Line 17: | Line 17: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Chemical/Poisoning''' | | '''Chemical/Poisoning''' | ||
|bgcolor="Beige"| [[Acrylamide]], [[arsenic | |bgcolor="Beige"| [[Acrylamide]], [[arsenic]], [[heavy metals]], [[konzo]], [[lead]], [[mercury]], [[methanol]], [[organophosphates]], [[salicylate poisoning]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 49: | Line 49: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| [[3-methylglutaconic aciduria]], [[Leukoencephalopathy|4H syndrome]], [[abetalipoproteinemia]], [[adrenoleukodystrophy]], [[adrenomyeloneuropathy]], [[alpha-mannosidase deficiency]], [[AMACR|alpha-methylacyl-CoA racemase deficiency]], [[argininosuccinic aciduria]], [[Metachromatic leukodystrophy|arylsulphatase A deficiency]], [[aspartoacylase deficiency]], [[ataxia-telangiectasia]], [[Cutis laxa|ATP6V0A2-related cutis laxa]], [[bilateral frontoparietal polymicrogyria]], [[biotinidase deficiency]], [[carbamoylphosphate synthetase deficiency]], [[carbohydrate deficient glycoprotein syndrome type 1a | |bgcolor="Beige"| [[3-methylglutaconic aciduria]], [[Leukoencephalopathy|4H syndrome]], [[abetalipoproteinemia]], [[adrenoleukodystrophy]], [[adrenomyeloneuropathy]], [[alpha-mannosidase deficiency]], [[AMACR|alpha-methylacyl-CoA racemase deficiency]], [[argininosuccinic aciduria]], [[Metachromatic leukodystrophy|arylsulphatase A deficiency]], [[aspartoacylase deficiency]], [[ataxia-telangiectasia]], [[Cutis laxa|ATP6V0A2-related cutis laxa]], [[bilateral frontoparietal polymicrogyria]], [[biotinidase deficiency]], [[carbamoylphosphate synthetase deficiency]], [[carbohydrate deficient glycoprotein syndrome type 1a]], [[SACS (gene)|Charlevoix-Saguenay spastic ataxia]], [[Cockayne syndrome]], [[Mitochondrial disease|coenzyme Q10 deficiency]], [[De Grouchy Syndrome]], [[dentatorubral-pallidoluysian atrophy]], [[Fabry's disease]], [[familial alphalipoprotein deficiency]], [[Friedreich's ataxia]], [[Hyperkalemic periodic paralysis|Gamstorp-Wohlfart syndrome]], [[glucose phosphate isomerase deficiency]], [[GM2 gangliosidosis]], [[Griscelli syndrome]], [[Haw river syndrome]], [[hereditary neuralgic amyotrophy]], [[Huntington disease]], [[hypobetalipoproteinemia]], [[Joubert syndrome]], [[Loken Senior syndrome]], [[Marinesco-Sjogren syndrome]], [[MELAS]], [[MERRF]], [[MPV17|MPV17 gene mutation]], [[Biotinidase deficiency|multiple carboxylase deficiency]], [[Phenylketonuria|phenylalanine hydroxylase deficiency]], [[progressive external ophthalmoplegia]], [[Refsum disease]], [[Charcot-Marie-Tooth Syndrome|Roussy-Levy disease]], [[Sandhoff disease]], [[KCNJ10|SeSAME syndrome]], [[Silver-Russell dwarfism|Silver syndrome]], [[SPG20|Troyer syndrome]], [[Unverricht-Lundborg disease]], [[Van der Knaap disease]], [[Von Hippel-Lindau syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 81: | Line 81: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Oncologic''' | | '''Oncologic''' | ||
|bgcolor="Beige"| [[Acoustic neuroma]], [[Medulloblastoma|cerebellar tumors]], [[chondroma]], [[Ewing's sarcoma]], [[Hodgkin's lymphoma]], [[lung carcinoma]], [[neuroblastoma]], [[neurofibromatosis type 1]], [[Non-Hodgkin lymphoma|non-Hodgkin's lymphoma]], [[osteochondroma]], [[osteoma]], [[osteosarcoma]], [[paraneoplastic syndrome]], [[rhabdomyosarcoma]], [[ | |bgcolor="Beige"| [[Acoustic neuroma]], [[Medulloblastoma|cerebellar tumors]], [[chondroma]], [[Ewing's sarcoma]], [[Hodgkin's lymphoma]], [[lung carcinoma]], [[neuroblastoma]], [[neurofibromatosis type 1]], [[Non-Hodgkin lymphoma|non-Hodgkin's lymphoma]], [[osteochondroma]], [[osteoma]], [[osteosarcoma]], [[paraneoplastic syndrome]], [[rhabdomyosarcoma]], [[plasmacytoma]], [[spinal cord tumor]], | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Ophthalmologic''' | | '''Ophthalmologic''' | ||
|bgcolor="Beige"| [[Cataract]], [[central serous chorioretinopathy | |bgcolor="Beige"| [[Cataract]], [[central serous chorioretinopathy]], [[cortical visual impairment]], [[endophthalmitis]], [[Dyskeratosis congenita|Hoyeraal-Hreidarsson syndrome]], [[hyphema]], [[Guillain-Barré syndrome|Miller-Fisher syndrome]], [[ocular ischemic syndrome]], [[ophthalmia neonatorum]], [[progressive external ophthalmoplegia]], [[retinal degeneration]], [[retrolental fibroplasia]], [[visual impairment]], [[vitreous hemorrhage]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 156: | Line 156: | ||
*[[Anemia]] | *[[Anemia]] | ||
*[[Ankylosing spondylitis]] | *[[Ankylosing spondylitis]] | ||
*[[ | *[[Antihypertensives]] | ||
*[[Cerebellar ataxia|Anti-glutamic acid decarboxylase associated cerebellar ataxia]] | *[[Cerebellar ataxia|Anti-glutamic acid decarboxylase associated cerebellar ataxia]] | ||
*[[Antibiotics]] | *[[Antibiotics]] | ||
| Line 188: | Line 188: | ||
*[[Botulism]] | *[[Botulism]] | ||
*[[Encephalitis|Brainstem encephalitis]] | *[[Encephalitis|Brainstem encephalitis]] | ||
*[[Briquet's syndrome]] | *[[Somatization disorder|Briquet's syndrome]] | ||
*[[Brucellosis]] | *[[Brucellosis]] | ||
*[[Capecitabine]] | *[[Capecitabine]] | ||
| Line 199: | Line 199: | ||
*[[Carpal tunnel syndrome]] | *[[Carpal tunnel syndrome]] | ||
*[[Cataract]] | *[[Cataract]] | ||
*[[Celecoxib]] | *[[Celecoxib]] | ||
*[[Celiac disease]] | *[[Celiac disease]] | ||
| Line 209: | Line 208: | ||
*[[Intracranial hemorrhage|Cerebellar hemorrhage]] | *[[Intracranial hemorrhage|Cerebellar hemorrhage]] | ||
*[[Medulloblastoma|Cerebellar tumor]] | *[[Medulloblastoma|Cerebellar tumor]] | ||
*[[Dandy-Walker | *[[Dandy-Walker syndrome|Cerebellar vermis agenesis]] | ||
*[[Cerebral palsy]] | *[[Cerebral palsy]] | ||
*[[Cerebrotendineous xanthomatosis]] | *[[Cerebrotendineous xanthomatosis]] | ||
| Line 235: | Line 234: | ||
*[[Compartment syndrome]] | *[[Compartment syndrome]] | ||
*[[Delirium|Confusional state]] | *[[Delirium|Confusional state]] | ||
*[[Congestive cardiac failure]] | *[[Congestive cardiac failure]] | ||
*[[Connective tissue disease]] | *[[Connective tissue disease]] | ||
| Line 246: | Line 244: | ||
*[[Cytomegalovirus|Cytomegalovirus polyradiculopathy]] | *[[Cytomegalovirus|Cytomegalovirus polyradiculopathy]] | ||
*[[Cytosine arabinoside]] | *[[Cytosine arabinoside]] | ||
*[[Dandy- | *[[Dandy-Walker syndrome]] | ||
*[[Dapsone]] | *[[Dapsone]] | ||
*[[Neuropathy|Deafferentation]] | *[[Neuropathy|Deafferentation]] | ||
*[[Myelopathy|Decompression sickness myelopathy]] | *[[Myelopathy|Decompression sickness myelopathy]] | ||
*[[De Grouchy Syndrome]] | |||
*[[Dehydration]] | *[[Dehydration]] | ||
*[[Dejerine Sottas syndrome]] | *[[Dejerine Sottas syndrome]] | ||
| Line 261: | Line 260: | ||
*[[Diabetic ketoacidosis ]] | *[[Diabetic ketoacidosis ]] | ||
*[[Diabetic neuropathy|Diabetic radiculopathy]] | *[[Diabetic neuropathy|Diabetic radiculopathy]] | ||
*[[Idiopathic pulmonary fibrosis|Diffuse pulmonary fibrosis]] | *[[Idiopathic pulmonary fibrosis|Diffuse pulmonary fibrosis]] | ||
*[[Schilder's disease|Diffuse sclerosis of | *[[Schilder's disease|Diffuse sclerosis of Schilder]] | ||
*[[Diphenhydramine]] | *[[Diphenhydramine]] | ||
*[[Diphtheria]] | *[[Diphtheria]] | ||
| Line 269: | Line 267: | ||
*[[Disulfiram]] | *[[Disulfiram]] | ||
*[[Diuretics]] | *[[Diuretics]] | ||
*[[Dothiepin ]] | *[[Dothiepin]] | ||
*[[Duchenne muscular dystrophy]] | *[[Duchenne muscular dystrophy]] | ||
*[[Dural arteriovenous fistula]] | *[[Dural arteriovenous fistula]] | ||
| Line 275: | Line 273: | ||
*[[Ramsay-Hunt syndrome|Dyssynergia cerebellaris myoclonica]] | *[[Ramsay-Hunt syndrome|Dyssynergia cerebellaris myoclonica]] | ||
*[[Electrical injury]] | *[[Electrical injury]] | ||
{{col-break|width=33%}} | |||
*[[Emotions]] | *[[Emotions]] | ||
*[[Encephalocele]] | *[[Encephalocele]] | ||
*[[Encephalomyelitis]] | *[[Encephalomyelitis]] | ||
| Line 297: | Line 295: | ||
*[[Fluorouracil]] | *[[Fluorouracil]] | ||
*[[Friedreich's ataxia]] | *[[Friedreich's ataxia]] | ||
*[[Hyperkalemic periodic paralysis|Gamstorp-Wohlfart syndrome]] | *[[Hyperkalemic periodic paralysis|Gamstorp-Wohlfart syndrome]] | ||
*[[Fatigue|Generalized weakness]] | *[[Fatigue|Generalized weakness]] | ||
*[[Gerstmann- | *[[Gerstmann-Sträussler-Scheinker syndrome]] | ||
*[[Giant axonal neuropathy]] | *[[Giant axonal neuropathy]] | ||
*[[Glucose phosphate isomerase deficiency]] | *[[Glucose phosphate isomerase deficiency]] | ||
*[[ | *[[GM2 gangliosidosis]] | ||
*[[Gout]] | *[[Gout]] | ||
*[[Griscelli syndrome]] | *[[Griscelli syndrome]] | ||
*[[Guillain- | *[[Guillain-Barré syndrome]] | ||
*[[Haemochromatosis]] | *[[Haemochromatosis]] | ||
*[[Hartnup disease ]] | *[[Hartnup disease ]] | ||
| Line 348: | Line 344: | ||
*[[Small fiber peripheral neuropathy|Idiopathic small fiber neuropathy]] | *[[Small fiber peripheral neuropathy|Idiopathic small fiber neuropathy]] | ||
*[[Hearing impairment|Impaired hearing]] | *[[Hearing impairment|Impaired hearing]] | ||
*[[Fistula|Intestinal fistula]] | *[[Fistula|Intestinal fistula]] | ||
*[[Intracranial space-occupying lesion]] | *[[Intracranial space-occupying lesion]] | ||
| Line 355: | Line 350: | ||
*[[Ixabepilone]] | *[[Ixabepilone]] | ||
*[[Joubert syndrome]] | *[[Joubert syndrome]] | ||
*[[Kearns- | *[[Kearns-Sayre syndrome]] | ||
*[[Klumpke paralysis]] | *[[Klumpke paralysis]] | ||
*[[Konzo]] | *[[Konzo]] | ||
| Line 365: | Line 360: | ||
*[[Leigh syndrome]] | *[[Leigh syndrome]] | ||
*[[Leprosy]] | *[[Leprosy]] | ||
*[[Lesch- | *[[Lesch-Nyhan syndrome]] | ||
*[[Leukemia]] | *[[Leukemia]] | ||
*[[Linezolid]] | *[[Linezolid]] | ||
| Line 380: | Line 375: | ||
*[[Malingering]] | *[[Malingering]] | ||
*[[Maple syrup urine disease]] | *[[Maple syrup urine disease]] | ||
*[[Marinesco- | *[[Marinesco-Sjogren syndrome]] | ||
*[[Mefloquine ]] | *[[Mefloquine ]] | ||
*[[Melarsoprol]] | *[[Melarsoprol]] | ||
| Line 390: | Line 385: | ||
*[[MERRF]] | *[[MERRF]] | ||
*[[Metabolic acidosis]] | *[[Metabolic acidosis]] | ||
*[[Metachromatic leukodystrophy ]] | *[[Metachromatic leukodystrophy]] | ||
*[[Methanol ]] | *[[Methanol ]] | ||
*[[Metronidazole]] | *[[Metronidazole]] | ||
| Line 399: | Line 394: | ||
*[[Mixed connective tissue disease]] | *[[Mixed connective tissue disease]] | ||
*[[Monoclonal gammopathy]] | *[[Monoclonal gammopathy]] | ||
*[[MPV17|MPV17 gene mutation]] | |||
*[[Multifocal motor neuropathy]] | *[[Multifocal motor neuropathy]] | ||
*[[Biotinidase deficiency|Multiple carboxylase deficiency]] | *[[Biotinidase deficiency|Multiple carboxylase deficiency]] | ||
| Line 407: | Line 403: | ||
*[[Neuropathy|Multiple sensory defect dizziness]] | *[[Neuropathy|Multiple sensory defect dizziness]] | ||
*[[Shy-Drager syndrome|Multiple system atrophy syndromes]] | *[[Shy-Drager syndrome|Multiple system atrophy syndromes]] | ||
*[[Muscle weakness | *[[Muscle weakness ]] | ||
*[[Myasthenia gravis]] | *[[Myasthenia gravis]] | ||
*[[Mycoplasma pneumoniae]] | *[[Mycoplasma pneumoniae]] | ||
| Line 414: | Line 410: | ||
*[[Nalidixic acid ]] | *[[Nalidixic acid ]] | ||
*[[Neuropathy, ataxia, and retinitis pigmentosa|NARP syndrome]] | *[[Neuropathy, ataxia, and retinitis pigmentosa|NARP syndrome]] | ||
*[[Neuroblastoma]] | *[[Neuroblastoma]] | ||
*[[Neurofibromatosis type 1]] | *[[Neurofibromatosis type 1]] | ||
*[[Neuroleptics]] | *[[Neuroleptics]] | ||
*[[Neuronal ceroid lipofuscinosis]] | *[[Neuronal ceroid lipofuscinosis]] | ||
*[[Niemann- | *[[Niemann-Pick disease]] | ||
*[[Nitrofurantoin]] | *[[Nitrofurantoin]] | ||
*[[Non-Hodgkin's lymphoma]] | *[[Non-Hodgkin's lymphoma]] | ||
| Line 440: | Line 435: | ||
*[[Osteoma]] | *[[Osteoma]] | ||
*[[Osteomyelitis]] | *[[Osteomyelitis]] | ||
*[[ | *[[Osteosarcoma]] | ||
*[[Oxaliplatin]] | *[[Oxaliplatin]] | ||
*[[Paclitaxel]] | *[[Paclitaxel]] | ||
*[[Pagets disease]] | *[[Pagets disease]] | ||
*[[Pain]] | *[[Pain]] | ||
*[[Pantothenate kinase ]] | *[[Pantothenate kinase]] | ||
*[[Paraneoplastic cerebellar degeneration]] | *[[Paraneoplastic cerebellar degeneration]] | ||
*[[Neuropathy|Paraneoplastic sensory neuropathy]] | *[[Neuropathy|Paraneoplastic sensory neuropathy]] | ||
| Line 451: | Line 446: | ||
*[[Paraproteinemia]] | *[[Paraproteinemia]] | ||
*[[Parkinson disease]] | *[[Parkinson disease]] | ||
*[[Pelizaeus- | *[[Pelizaeus-Merzbacher disease]] | ||
*[[Peripheral neuropathy]] | *[[Peripheral neuropathy]] | ||
*[[Pernicious anemia]] | *[[Pernicious anemia]] | ||
| Line 460: | Line 455: | ||
*[[Phenylbutazone ]] | *[[Phenylbutazone ]] | ||
*[[Phenytoin]] | *[[Phenytoin]] | ||
*[[Physostigmine | *[[Physostigmine]] | ||
*[[Plasmacytoma]] | *[[Plasmacytoma]] | ||
*[[Pleural effusion]] | *[[Pleural effusion]] | ||
| Line 481: | Line 475: | ||
*[[Pulmonary edema]] | *[[Pulmonary edema]] | ||
*[[Pulmonary embolism]] | *[[Pulmonary embolism]] | ||
*[[Pyloric stenosis]] | *[[Pyloric stenosis]] | ||
*[[Pyridoxine]] | *[[Pyridoxine]] | ||
| Line 488: | Line 481: | ||
*[[Radiotherapy]] | *[[Radiotherapy]] | ||
*[[Raised intracranial pressure]] | *[[Raised intracranial pressure]] | ||
*[[Refsum disease ]] | *[[Refsum disease]] | ||
*[[Reiter's syndrome]] | *[[Reiter's syndrome]] | ||
*[[Renal failure]] | *[[Renal failure]] | ||
*[[Retinal degeneration]] | *[[Retinal degeneration]] | ||
*[[Retrolental fibroplasia ]] | *[[Retrolental fibroplasia ]] | ||
*[[Rhabdomyosarcoma]] | *[[Rhabdomyosarcoma]] | ||
*[[Rheumatoid arthritis]] | *[[Rheumatoid arthritis]] | ||
*[[Rofecoxib ]] | *[[Rofecoxib ]] | ||
*[[Roussy-levy disease]] | *[[Charcot-Marie-Tooth Syndrome|Roussy-levy disease]] | ||
*[[Salicylate poisoning]] | *[[Salicylate poisoning]] | ||
*[[Salla disease]] | *[[Salla disease]] | ||
| Line 510: | Line 502: | ||
*[[Septicemia]] | *[[Septicemia]] | ||
*[[Seronegative spondyloarthritis]] | *[[Seronegative spondyloarthritis]] | ||
*[[SeSAME syndrome]] | *[[KCNJ10|SeSAME syndrome]] | ||
*[[Shy- | *[[Shy-Drager syndrome]] | ||
*[[Sialidosis ]] | *[[Sialidosis ]] | ||
*[[Sideroblastic anemia ]] | *[[Sideroblastic anemia ]] | ||
*[[Silver syndrome]] | *[[Silver-Russell dwarfism|Silver syndrome]] | ||
*[[Sjögren's syndrome]] | *[[Sjögren's syndrome]] | ||
*[[Slipped upper femoral epiphysis]] | *[[Slipped upper femoral epiphysis]] | ||
| Line 535: | Line 527: | ||
*[[Tarsal tunnel syndrome ]] | *[[Tarsal tunnel syndrome ]] | ||
*[[Taxol]] | *[[Taxol]] | ||
*[[Tay- | *[[Tay-Sachs disease ]] | ||
*[[Thallium]] | *[[Thallium]] | ||
*[[Thiamine deficiency]] | *[[Thiamine deficiency]] | ||
| Line 550: | Line 542: | ||
*[[Tuberculosis]] | *[[Tuberculosis]] | ||
*[[Typhoid fever]] | *[[Typhoid fever]] | ||
*[[Unverricht- | *[[Unverricht-Lundborg disease]] | ||
*[[Upper motor neuron weakness]] | *[[Spasticity|Upper motor neuron weakness]] | ||
*[[Uremia]] | *[[Uremia]] | ||
*[[Urination]] | *[[Urination]] | ||
*[[Vaccines]] | *[[Vaccines]] | ||
*[[Van der | *[[Van der Knaap disease]] | ||
*[[Vasculitis]] | *[[Vasculitis]] | ||
*[[Vasovagal syncope|Vasovagal attacks]] | *[[Vasovagal syncope|Vasovagal attacks]] | ||
| Line 569: | Line 561: | ||
*[[Von Hippel-Lindau syndrome]] | *[[Von Hippel-Lindau syndrome]] | ||
*[[Wilson disease ]] | *[[Wilson disease ]] | ||
*[[Xeroderma pigmentosum]] | *[[Xeroderma pigmentosum]] | ||
*[[Zalcitabine ]] | *[[Zalcitabine ]] | ||
Revision as of 15:23, 31 July 2013
|
Disequilibrium Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Disequilibrium On the Web |
|
American Roentgen Ray Society Images of Disequilibrium |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Vendhan Ramanujam M.B.B.S [2]
Synonyms and keywords: Loss of balance; imbalance; off balance; unsteadiness
Overview
Disequilibrium refers to an impaired sense or absence of balance or equilibrioception, which primarily occurs during standing or walking usually without any cephalic sensations like headache, nausea and vomiting. It is one among the causes of dizziness[1] and is often accompanied by spatial disorientation.
Causes
Life Threatening Causes
Common Causes
Causes by Organ System
Causes in Alphabetical Order
References
- ↑ "Chapter 14: Evaluation of the Dizzy Patient". Retrieved 2009-08-06.